Please login to the form below

Wilson Therapeutics

This page shows the latest Wilson Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion Pharma’s drive to reduce its reliance on cash cow Soliris has gone up a gear with a $855m offer for rare disease company Wilson Therapeutics. ... Ludwig Hantson, Alexion’s chief executive, said: “The acquisition of Wilson Therapeutics is a

Latest news

mRNA - message received

Arcturus Therapeutics. thrombopoietin; alpha-1 antitrypsin replacment; cystic fibrosis; iron disorders. Tekmira, Arrowhead. ... Shire. Eukarys. monogenic liver diseases; Wilson disease. Moderna Therapeutics. cancer; cardiovascular disease; infectious

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

IGEM Therapeutics appoints Dr Tim Wilson as CEO

IGEM Therapeutics appoints Dr Tim Wilson as CEO. He joins after the UK immuno-oncology firm raises £2m to advance its pipeline. ... Wilson has over 28 years’experience in the life sciences sector, ranging from venture capital and start-ups to
Therachon strengthens management team

He currently serves as chairman of Asceneuron, Complix and InteRNA, and as a non-executive director at Hansa Medical, Sobi, Wilson Therapeutics and Dutch Top Sector Life Sciences and Health.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Editor – Medical Education Agency – Bucks: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Account Manager – Med Comms – Kent: Salary TBC

Senior Medical Writer: Great salary and benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Editorial Director – Medical Education – Oxford: Negotiable

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Medical Writer: Great salary and bebefits

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Senior Programme Executive: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Senior Account Manager / Account Director: Great salary and bebefits

Senior Account Manager or AD - Medical Communications: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Scientific Director: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...